Company name
Dr. Consulta Ltd.
Project number
14462-01
Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.
E&S category 
B
Country
Brazil
Sector
Social Infrastructure
Status
Proposed
Disclosed date
04/28/2023
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
05/30/2023
Approval date
N/A
Signed date
N/A
Sponsoring entity
N/A
Team leader
Bianco del Barrio, Silvana
Investment type
Syndicated amount
N/A
Financing amount
USD $ 12,000,000
Currency
USD
Project scope and objective
Dr. Consulta is a healthcare technology (“HealthTech”) company providing low-cost care delivery to low-income patients with a multi-channel approach in Brazil.
The proposal consists of an equity investment of up to USD 12 million in Dr. Consulta Ltd. to support the entity to expand operations through the opening of new clinics, including other regions within Brazil, and to develop its technology and its recently acquired healthcare plans (“Cuidar.me”).
The investment of up to US$10 million will take place as preferred convertible stock as part of the ongoing Series D equity round, with an estimated term of 7 years term. An additional 20% uncommitted amount may be contributed exclusively to exercise preemptive rights and/or right of first refusal.
For inquiries, comments and information requests about the project
Request informationLearn more about how we provide private-sector solutions in the region.
Contact information
For inquiries, comments and information requests about the project
Request informationAlternatively, you may also use the following contact information:
Client Contact
CONTACT NAME
Mariana Carriao
POSITION
General Counsel
PHONE NUMBER
+55 (11) 41181510
marianafc@drconsulta.com
IDB Invest Contact
requestinformation@idbinvest.org
PHONE
+1(202)-566-4566
ADDRESS
1350 New York Ave NW, Washington, DC 20005
COUNTRY OFFICES
IDB Invest Country OfficesIndividuals or communities can submit complaints and concerns related to environmental, social, or corporate governance issues to the Management Grievance Mechanism by e-mailing mgm@iadb.org or by calling +1 202 312 4040.
As a last resort, affected communities have access to the IDB Invest Independent Consultation and Investigation Mechanism by writing to mecanismo@iadb.org or MICI@iadb.org or calling +1(292) 623-3952.
Environmental and social review
IDB Invest conducts an environmental and social due diligence (ESDD) commensurate with the nature, scale, and stage of the project, and with its level of environmental and social risks and impacts. The ESDD will confirm the project E&S categorization and assess the project with respect to the client requirements in IDB Invest Environmental and Social Sustainability Policy. The results of the ESDD, including any identified gaps are described in the Environmental and Social Review Summary (ESRS) provided below. For projects approved as of 2016, any gaps with respect to IDB Invest's Environmental and Social Sustainability Policy at the time of the ESDD are addressed in the Environmental and Social Action Plan (ESAP) presented below, to comply with the date mentioned above.
DR. CONSULTA - ENVIRONMENTAL AND SOCIAL REVIEW SUMMARY (ESRS)
890.9 Kb
DR. CONSULTA - ENVIRONMENTAL AND SOCIAL ACTION PLAN (ESAP)
389.1 Kb